Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double Blind, Placebo Controlled Exploratory Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Pulmonary Sarcoidosis

NCT03320070 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.

NCT NCT03320070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03320070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double Blind, Placebo Controlled Exploratory Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Pulmonary Sarcoidosis
Lead sponsor
Mallinckrodt
Phase
Phase 4
Overall status
Completed
Start date
February 21, 2018
Completion date
November 15, 2021
Enrollment
55 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoidosis, pulmonary